Adenovirus-mediated combined suicide gene and interleukin-2 gene therapy for the treatment of established tumor and induction of antitumor immunity

Journal of Cancer Research and Clinical Oncology

Volumn 124, Issue 12, 1998, Pages 683-689

  Ju, Dian Wen ^a   Wang, Bao Mei ^a   Cao, Xuetao ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Adenovirus; Antitumor immunity; Cytosine deaminase; Cytotoxic T lymphocytes; Gene therapy; Interleukin 2; Suicide gene

Indexed keywords

INTERLEUKIN 2;

ADENOVIRUS; ANTINEOPLASTIC ACTIVITY; ARTICLE; CYTOTOXIC T LYMPHOCYTE; ERYTHROLEUKEMIA; GENE THERAPY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SUICIDE GENE;

ADENOVIRIDAE; ANIMALS; ANTIMETABOLITES; CYTOSINE DEAMINASE; ESCHERICHIA COLI; FEMALE; FLUCYTOSINE; GENE THERAPY; GENE TRANSFER TECHNIQUES; INTERLEUKIN-2; MALE; MICE; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; NUCLEOSIDE DEAMINASES; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0001030918     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320050232     Document Type: Article

References (46)

1. Aghi M, Kramm CM, Chou TC, Breakefield XO, Chiocca EA (1998) Synergistic anticancer effects of ganciclovir, thymidine kinase and 5-fluorocytosine cytosine deaminase gene therapies. J Natl Cancer Inst 90:370-380
2. Bannerji R, Arroyo CD, Cordon-Cardo C, Gilboa E (1994) The role of IL-2 secreted from genetically modified tumor cells in the establishment of antitumor immunity. J Immunol 152:2324-2332
3. Barba D, Hardiu J, Sadelan M, Gage FH (1994) Development of antitumor immunity following thymidine kinase mediated killing of experimental brain tumors. Proc Natl Acad Sci USA 91:4348-4351
4. Benedetti S, Dimeco F, Pollo B, Cirenei N, Colombo BM, Bruzzone MG, Cattaneo E, Vescovi A, Didonato S, Colombo MP, Finocchiaro G (1997) Limited efficacy of the HSV-TK/GCV system for gene therapy of malignant gliomas and perspectives for the combined transduction of the interleukin-4 gene. Hum Gene Ther 8:1345-1353
5. Bi W, Kim YG, Feliciano ES, Pavelic L, Wilson KM, Pavelic ZP, Stambrook PJ (1997) An HSV tk-mediated local and distant antitumor bystander effect in tumors of head and neck origin in athymic mice. Cancer Gene Ther 4:246-252
6. Bubenik J, Simova J, Bubenikova D, Zeuthen J, Indrova M (1995) Interleukin-2 gene therapy of residual EL-4 leukaemia potentiates the effect of cyclophosphamide pretreatment. J Cancer Res Clin Oncol 121:39-43
7. Cao X, Zhang W, Gu S, Yu Y, Tao Q, Ye T (1995) Induction of antitumor immunity and treatment of preestablished tumors by inactivated II-6 gene transfected melanoma cells combined with low dose IL-2. J Cancer Res Clin Oncol 121:721-728
8. Cao X, Chen G, Zhang W, Tao Q, Yu Y, Ye T (1996) Enhanced efficacy of combination of IL 2 gene and IL 6 gene transfected tumor cells in the treatment of established metastatic tumors. Gene Ther 3:421-426
9. Cao X, Ju DW, Tao Q, Wang J, Wan T, Wang BM, Zhang WP, Hamada H (1998) Adenovirus-mediated GM-CSF gene and cytosine deaminase gene transfer followed by 5-fluorocytosine administration elicit more potent antitumor response in tumor-bearing mice. Gene Ther 5:1130-1136
10. Consalvo M, Mullen CA, Modesti A, Musiani P, Allione A, Cavallo F, Giovarelli M, Forni G (1995) 5-Fluorocytosine induced eradication of murine adenocarcinomas engineered to express the cytosine deaminase suicide gene requires host immune competence and leaves an efficient memory. J Immunol 154:5302-5312
11. Denning C, Pitts JD (1997) Bystander effects of different enzymeprodrug systems for cancer gene therapy depend on different pathways for intercellular transfer of toxic metabolites, a factor that will govern clinical choice of appropriate regimes. Hum Gene Ther 8:1825-1835
12. Deonarain MP, Spooner RA, Epenetos AA (1995) Genetic delivery of enzymes for cancer therapy. Gene Ther 2:235-244
13. Dilber MS, Abedi MR, Bjorkstrand B, Christensson B, Gahrton G, Xanthopoulos KG, Smith CI (1996) Suicide gene therapy for plasma cell tumors. Blood 88:2192-2200
14. Dong Y, Wen P, Manome Y, Parr M, Hirshowitz A, Chen L, Hirschowitz EA, Crystal R, Weichselbaum R, Kufe DW, Fine HA (1996) In vivo replication-deficient adenovirus vector-mediated transduction of the cytosine deaminase gene sensitizes glioma cells to 5-fluorocytosine. Hum Gene Ther 7:713-720
15. Ellerhorst JA, Sella A, Amato RJ, Tu SM, Millikan RF, Finn LD, Banks M, Logothetis CJ (1997) Phase II trial of 5-fluorouracil, interferon-alpha and continuous infusion interleukin-2 for patients with metastatic renal cell carcinoma. Cancer 80:2128-2132
16. Evoy D, Hirschowitz EA, Naama HA, Li XK, Crystal RG, Daly JM, Lieberman MD (1997) In vivo adenoviral-mediated gene transfer in the treatment of pancreatic cancer. J Surg Res 69:226-231
17. Foa R (1996) Interleukin 2 in the management of acute leukaemia. Br J Haematol 92:1-8
18. Freeman SM, Ramesh R, Marrogi AJ (1997) Immune system in suicide-gene therapy. The Lancet 349:2-3
19. Hanna NN, Mauceri HJ, Wayne JD, Hallahan DE, Kufe DW, Weichselbaum RR (1997) Virally directed cytosine deaminase, 5-fluorocytosine gene therapy enhances radiation response in human cancer xenografts. Cancer Res 57:4205-4209
20. Harris JD, Gutierrez AA, Hurst HC, Sikora K, Lemoine NR, Harris JD, Gutierrez AA, Hurst HC, Sikora K, Lemoine NR (1994) Gene therapy for cancer using tumor-specific prodrug activation. Gene Ther 1:170-175
21. Heaton KM, Grimm EA (1993) Cytokine combinations in immunotherapy for solid tumors: a review. Cancer Immunol Immunother 37:213-219
22. Hirschowitz EA, Ohwada A, Pascal WR, Russi TJ, Crystal RG (1995) In vivo ademnirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine. Hum Gene Ther 6:1055-1063
23. Ishii-Morita H, Agbaria R, Mullen CA, Hirano H, Koeplin DA, Ram Z, Oldfield EH, Johns DG, Blaese RM (1997) Mechanism of 'bystander effect' killing in the herpes simplex thymidine kinase gene therapy model of cancer treatment. Gene Ther 4:244-251
24. Ju DW, Cao X, Acres B (1997) Intratumoral injection of GM-CSF gene encoded recombinant vaccinia virus elicits potent antitumor response in a murine melanoma model. Cancer Gene Ther 4:139-144
25. Kanai F, Lan KH, Shiratori Y, Tanaka T, Ohashi M, Okudaira T, Yoshida Y, Wakimoto H, Hamada H, Nakabayashi H, Tamaoki T, Omata M (1997) In vivo gene therapy for alpha fetoprotein producing hepatocellular carcinoma by adenovirus mediated transfer of cytosine deaminase gene. Cancer Res 57:461-465
26. Katsanis E, Orchard PJ, Bausero MA, Gorden KB, McIvor RS, Blazer BR (1994) Interleukin-2 gene transfer into murine neuroblastoma decreases tumorigenicity and enhances systemic immunity causing regression of preestablished retroperitoneal tumors. J Immunother 15:81-90
27. Kianmanesh AR, Perrin H, Panis Y, Fabre M, Nagy HJ, Houssin D, Klatzmann D (1997) A "distant" bystander effect of suicide gene therapy: regression of nontransduced tumors together with a distant transduced tumor. Hum Gene Ther 8:1807-1814
28. Klatzmann D (1996) Gene therapy for metastatic malignant melanoma: evaluation of tolerance to intratumorul injection of cells producing recombinant retroviruses carrying the herpes simplex virus type 1 thymidine kinase gene, to be followed by ganciclovir administration. Hum Gene Ther 7:255-267
29. Kopantzev E, Roschke V, Rudikoff S (1998) Interleukin-2-mediated modulation of plasma cell tumor growth in a model of multiple myeloma. Hum Gene Ther 9:13-19
30. Kwong YL, Chen SH, Kosai K, Finegold M, Woo SL (1997) Combination therapy with suicide and cytokine genes for hepatic metastases of lung cancer. Chest 122:1332-1337
31. Legha SS, Gianan MA, Eton OE, Papadopoulous NEJ (1996) Evaluation of interleukin-2 administrated by continuous infusion in patients with metastatic melanoma. Cancer 77:89-96
32. Li Z, Shanmugam N, Katayose D, Huber B, Srivastava S, Cowan K, Seth P (1997) Enzyme/prodrug gene therapy approach for breast cancer using a recombinant adenovirus expressing Escherichia coli cytosine deaminase. Cancer Gene Ther 4:113-117
33. Mullen CA (1994) Metabolic suicide genes in gene therapy. Pharmacol Ther 63:199-207
34. Nanni P, De Giovanni C, Nicoletti G, Landuzzi L, Rossi I, Frabetti F, Giovarelli M, Forni G, Cavallo F, Di Carlo E, Musiani P, Lollini PL (1998) The immune response elicited by mammary adenocarcinoma cells transduced with interferon-gamma and cytosine deaminase genes cures lung metastases by parental cells. Hum Gene Ther 9:217-224
35. Nestler U, Heinkelein M, Lucke M, Meixensberger J, Scheurlen W, Kretschmer A, Rethwilm A (1997) Foamy virus vectors for suicide gene therapy. Gene Ther 4:1270-1277
36. Pederson LC, Buchsbaum DJ, Vickers SM, Kuncharla SR, Mayo MS, Curiel DT, Stackhouse MA (1997) Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo. Cancer Res 57:4325-4332
37. Richards CA, Austin EA, Huber BE (1995) Transcriptional regulatory sequences of carcinoembryonic antigen: identification and use with cytosine deaminase for tumor specific gene therapy. Hum Gene Ther 6:881-893
38. Rogulski KR, Kim JH, Kim SH, Freytag SO (1997) Glioma cells transduced with an Escherichia coli CD/HSV 1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity. Hum Gene Ther 8:73-85
39. Rosenberg SA, Yang JC, Topalian SL, Schwartzentruber DJ, Weber JS, Parkinson DR, Seipp CA, Einhorn JH, White DE (1994) Treatment of 283 consecutive patients wit metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2. JAMA 271:907-913
40. Santodonato L, Ferrantini M, Gabriele L, Proietti E, Venditti M, Musiani P, Modesti A, Modica A, Lupton SD, Belardelli F (1996) Cure of mice with established metastatic friend leukemia cell tumors by a combined therapy with tumor cells expressing both interferon-α1 and herpes simplex thymidine kinase followed by ganciclovir. Gene Ther 7:1-10
41. Savage P, Costelna D, Moore J, Gore ME (1997) A phase II study of continuous infusional 5-fluorouracil (5-FU) and subcutaneous interleukin-2 (IL-2) in metastatic renal cancer. Eur J Cancer 33:1149-1151
42. Szala S, Missol E, Sochanik A, Strozyk M (1996) The use of cationic liposomes DCCHOL/DOPE and DDAB/DOPE for direct transfer of Escherichia coli cytosine deaminase gene into growing melanoma tumors. Gene Ther 3:1026-1031
43. Tiberghien P (1994) Use of suicide genes in gene therapy. J Leukoc Biol 56:203-209
44. Waxman S, Huang Y, Scher BM, Scher M (1992) Enhancement of differentiation and cytotoxicity of leukemia cells by combinations of fluorinated pyrimidines and differentiation inducers: development of DNA double-strand breaks. Biomed Pharmacother 46:183-192
45. Yang YW, Chang YH (1995) Induction of erythroid differentiation by 5-fluorouracil in K562 leukemia cells. Jpn J Cancer Res 86:948-955
46. Yu Y, Cao X, Xu Z (1995) Combined therapeutic effects of IL-2 gene and IL-4 gene transfected tumor vaccines on pulmonary metastatic melanoma and its immunological mechanisms. Chin J Microbiol Immunol 15:397-401